6 p.m. CET – In accordance with the provisions of Article L.233-8 II of the French Commercial...
ADOCIA
(AOF) – Adocia, a biotech company specializing in the treatment of diabetes and other metabolic diseases, announces...
(CercleFinance.com) – The Caisse des dépôts et consignations (CDC) declared to the AMF that it crossed downwards,...
ADOCIA: Information relating to the number of shares and voting rights as of December 31, 2022. 6:00...
6:00 p.m. CET – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the...
• Adocia’s partner, Tonghua Dongbao, announced that the primary endpoint of this Phase 1 study has been...
(AOF) – Adocia, a clinical-stage biopharmaceutical company specializing in the research and development of innovative therapeutic solutions...
(CercleFinance.com) – The title Adocia wins more than 10% Thursday morning on the Paris Stock Exchange following...
6:00 p.m. CET – Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specializing in the...
ADOCIA: Information relating to the number of shares and voting rights as of November 30, 2022 6...
ADOCIA: Information relating to the number of shares and voting rights as of October 31, 2022 6...
(AOF) – Adocia, a biopharmaceutical company, has published its cash position and its turnover for the third...
